Evidence map›Paper›PMID 21607559›Full record

ArticleRheumatology international2012

Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course.

Mara Anaís Llamas-Covarrubias, Yeminia Valle, Rosa Elena Navarro-Hernández, Iris Paola Guzmán-Guzmán, María Guadalupe Ramírez-Dueñas, Héctor Rangel-Villalobos, Ciro Estrada-Chávez, José Francisco Muñoz-Valle

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04315818 (The Relation Between Macrophage Migration Inhibitory Factor), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04315818 unknown statusnot on this mapstarted 2021, after this paper: background citation

The Relation Between Macrophage Migration Inhibitory Factor (MIF) and 25(OH) Vitamin D3 Serum Levels in Rheumatoid Arthritis

TypeobservationalSponsorAssiut UniversityRan2021 to 2023Enrolled70ConditionsRheumatoid Arthritis
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Macrophage Migration Inhibitory Factor -173GC Variant Might Increase the Risk of Behçet's Disease.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2018
    Article
  13. Cardiology research and practice · 2018
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mara Anaís Llamas-CovarrubiasDoctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada #950, Col. Independencia, 44348 Guadalajara, Jalisco, Mexico.
Yeminia Valle
Rosa Elena Navarro-Hernández
Iris Paola Guzmán-Guzmán
María Guadalupe Ramírez-Dueñas
Héctor Rangel-Villalobos
Ciro Estrada-Chávez
José Francisco Muñoz-Valle
Universidad de Guadalajara · MXSecretaría de Salud de Jalisco · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is an inflammatory autoimmune disease of unknown etiology. Many cytokines have been found to be associated with RA pathogenesis and among them is macrophage migration inhibitory factor (MIF). The aim of this study was to determine whether MIF serum levels are associated with RA course, clinical activity, and clinical biomarkers of the disease. MIF levels were determined in serum samples of 54 RA patients and 78 healthy subjects (HS) by enzyme-linked immunosorbent assay (ELISA). Disease activity was evaluated using the DAS28 score. Patients were subgrouped according to disease activity and years of evolution of disease. Statistical analysis was carried out by SPSS 10.0 and GraphPad Prism 5 software. RA patients presented increased levels of MIF as compared to HS. MIF levels were raised on early stages of RA and tend to decrease according to years of evolution. Moreover, MIF levels positively correlated with rheumatoid factor in RA patients and with C reactive protein in all individuals studied. Our findings suggest that MIF plays a role in early stages of RA.

Indexed as

AdultAgedAntirheumatic AgentsArthritis, RheumatoidBiomarkersCase-Control StudiesC-Reactive ProteinCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMaleMexicoMiddle AgedAntirheumatic AgentsBiomarkersC-Reactive ProteinIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMIF protein, humanRheumatoid Factor

Identifiers

PMID21607559
OpenAlexW2006062488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.